Abstract | PURPOSE: MATERIALS AND METHODS: Anti-MMP-7 antibodies were measured in sera from 204 patients with OSCC and 212 normal controls using enzyme-linked immunosorbent assay, and clinicopathologic characteristics were correlated. Prognostic consequence was assessed with Kaplan-Meier curve and log-rank tests using Cox proportional hazard models. To check whether anti-MMP-7 antibody was related to tumor associated antigen, real-time polymerase chain reaction and western blot were used to measure MMP-7 mRNA and protein expression in tumor tissues from all 204 patients with OSCC. RESULTS: Serum anti-MMP-7 antibody was higher in patients with OSCC (P < .05), and those with poorly differentiated tumors had more anti-MMP-7 antibody than those with well to moderate tumor differentiation (P < .01, P < .01, respectively). Patients with OSCC at late TNM stages (III, IV) and lymph node metastases had relatively higher serum anti-MMP-7 antibody levels than those with earlier stages (I, II) and those who lacked lymph node metastases (P < .05 for the 2 comparisons). OSCC prediction sensitivity as measured by receiver operating characteristics analysis was 0.485 and specificity was 0.896 (area under the curve, 0.761; 95% confidence interval, 0.716 to 0.806). Cox analysis showed that serum anti-MMP-7 antibody positivity independently predicted poor overall survival in patients with OSCC (hazard ratio, 1.82; 95% confidence interval, 1.07 to 4.61). MMP-7 mRNA and protein expression was increased in tumor tissues from patients with OSCC and high serum anti-MMP-7 antibody. CONCLUSION: Serum anti-MMP-7 antibody might be a novel diagnostic and prognostic biomarker for OSCC.
|
Authors | Tao Jiang, Pengfeng Xie, Hongchen Liu |
Journal | Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
(J Oral Maxillofac Surg)
Vol. 74
Issue 3
Pg. 650-7
(Mar 2016)
ISSN: 1531-5053 [Electronic] United States |
PMID | 26454036
(Publication Type: Comparative Study, Journal Article)
|
Copyright | Copyright © 2016 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Autoantibodies
- Biomarkers, Tumor
- MMP7 protein, human
- Matrix Metalloproteinase 7
|
Topics |
- Aged
- Area Under Curve
- Autoantibodies
(blood)
- Biomarkers, Tumor
(blood)
- Carcinoma, Squamous Cell
(blood, diagnosis, pathology)
- Case-Control Studies
- Electrophoresis, Polyacrylamide Gel
(methods)
- Female
- Follow-Up Studies
- Humans
- Lymphatic Metastasis
(pathology)
- Male
- Matrix Metalloproteinase 7
(analysis, immunology)
- Middle Aged
- Mouth Neoplasms
(blood, diagnosis, pathology)
- Neoplasm Grading
- Neoplasm Staging
- Prognosis
- Proportional Hazards Models
- ROC Curve
- Retrospective Studies
- Sensitivity and Specificity
- Survival Rate
|